ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,586Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 97

$907K Total Retail Price of All Prescriptions

Rank: 10 out of 97

579 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Dakota
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 579 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

4% of this provider’s 579 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 19,892 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Dakota
SIMVASTATIN 1,164 1,078 1 2
LISINOPRIL 822 750 2 4
FUROSEMIDE 748 725 3 3
METOPROLOL SUCCINATE 729 727 4 8
OMEPRAZOLE 726 721 5 5
LEVOTHYROXINE SODIUM 693 686 6 1
AMLODIPINE BESYLATE 663 636 7 6
METOPROLOL TARTRATE 552 527 8 7
CITALOPRAM HBR 456 455 9 20
METFORMIN HCL 452 409 10 12
TRAMADOL HCL 416 408 11 21
POTASSIUM CHLORIDE 398 390 12 10
TAMSULOSIN HCL 369 357 13 31
ISOSORBIDE MONONITRATE ER 349 342 14 27
ATORVASTATIN CALCIUM 324 323 15 14
DONEPEZIL HCL 297 293 16 24
WARFARIN SODIUM 275 275 17 11
ATENOLOL 264 258 18 15
LOSARTAN POTASSIUM 251 251 19 13
MIRTAZAPINE 234 234 20 35
HYDROCHLOROTHIAZIDE 221 210 21 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 215 213 22 36
CARVEDILOL 214 212 23 25
ALLOPURINOL 212 212 24 22
GABAPENTIN 209 209 25 18
JANTOVEN 201 201 26 37
ZETIA 196 184 27 51
ALENDRONATE SODIUM 187 187 28 19
JANUVIA 171 155 29 59
PAROXETINE HCL 171 158 29 56
TRIAMTERENE-HCTZ 170 162 31 30
DIGOXIN 169 169 32 26
RANITIDINE HCL 164 164 33 67
LOSARTAN-HYDROCHLOROTHIAZIDE 158 155 34 49
CLOPIDOGREL 156 148 35 34
AVODART 152 140 36 94
DIOVAN 150 150 37 44
NAMENDA 150 150 37 38
PLAVIX 149 144 39 46
CRESTOR 141 141 40 29
PRAVASTATIN SODIUM 140 140 41 28
LACTULOSE 134 134 42 103
ADVAIR DISKUS 132 128 43 40
HYDRALAZINE HCL 126 120 44 84
FINASTERIDE 118 118 45 58
QUETIAPINE FUMARATE 117 112 46 82
HYDROCODONE-ACETAMINOPHEN 116 116 S3 47 17
LOVASTATIN 112 110 48 62
LANTUS 107 98 49 43
CARBIDOPA-LEVODOPA 99 95 50 61
SERTRALINE HCL 99 99 50 16
GEMFIBROZIL 99 88 50 104
MELOXICAM 97 91 53 87
DOXAZOSIN MESYLATE 96 85 54 45
PEN NEEDLE 88 86 55 57
BUSPIRONE HCL 86 86 56 107
SPIRIVA 81 81 57 48
ACTOS 79 64 58 152
LANTUS SOLOSTAR 77 77 59 41
NEXIUM 75 75 60 66
PANTOPRAZOLE SODIUM 74 74 61 53
NOVOLOG 73 72 62 123
EVISTA 71 71 63 129
PREDNISONE 71 69 63 23
LEVEMIR FLEXPEN 71 67 63 133
KLOR-CON 10 70 65 66 65
BISOPROLOL-HYDROCHLOROTHIAZIDE 69 69 67 102
GLYBURIDE 69 69 R 67 75
INSULIN SYRINGE 67 66 69 88
SPIRONOLACTONE 63 61 70 33
OXYBUTYNIN CHLORIDE 63 56 70 144
GLIMEPIRIDE 62 62 72 39
CYMBALTA 61 61 73 80
METHIMAZOLE 56 56 74 222
FENOFIBRATE 56 56 74 113
TERAZOSIN HCL 55 55 76 106
SEROQUEL 55 54 76 142
DETROL LA 54 54 78 119
LYRICA 51 28 79 100
LEVEMIR 51 51 79 159
VERAPAMIL ER 51 51 79 90
NYSTOP 50 49 82 235
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 23, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.